CQDM’s funding program for Quantum Leap biopharmaceutical research helps Canadian SMEs and universities undertake innovative translational R&D projects in collaboration with large biopharmaceutical organizations. The chosen projects aim to develop cutting-edge technologies with a potentially significant impact on the R&D activities of CQDM biopharmaceutical members. Quantum Leap projects are undertaken in close collaboration and with expert support and funding from our pharmaceutical members. Enabling technologies, pioneering platforms and/or innovative therapeutic methods developed should seek to improve, facilitate and/or considerably accelerate the discovery and development process for safer, more effective drugs. The technologies in question target all stages of drug development and cover a wide range of therapeutic indications. Projects are expected to generate tangible deliverables to be used by CQDM’s pharmaceutical members, once the project has been completed. Funded research offers researchers a perfect opportunity to secure future collaborations with the industry worldwide.
Explore similar funding opportunities that match your goals.